Agenus logo

Agenus AGEN

$ 6.39 2.57%
report update icon

Quarterly report 2026-Q3
added 11-05-2026

Country

usaUSA

IPO year

2000

Industry

Biotechnology

Stock Exchange

NASDAQ CAPITAL

Shares

29.7 M

Market Cap[1]

$ 190 M

EBITDA (LTM)

$ 44.7 M

P/E (LTM)

9.58209

P/S (LTM)

1.425144

EPS (LTM)

0.67

Other stocks of industry "Biotechnology"

Issuer Price % 24h Market Cap Exchange Country
Brickell Biotech Brickell Biotech
BBI
- -5.38 % $ 6.06 M Nasdaq Capital Market usaUSA
Applied Therapeutics Applied Therapeutics
APLT
- - $ 8.42 M Nasdaq Global Market,SPB usaUSA
ESSA Pharma ESSA Pharma
EPIX
- - $ 8.86 M Nasdaq Capital Market canadaCanada
Generation Bio Co. Generation Bio Co.
GBIO
- - $ 344 M Nasdaq Global Select Market usaUSA
Clearside Biomedical Clearside Biomedical
CLSD
- - $ 25.3 M Nasdaq Global Market usaUSA
Merus N.V. Merus N.V.
MRUS
- - $ 5.78 B Nasdaq Global Select Market niderlandNiderland
RAPT Therapeutics RAPT Therapeutics
RAPT
- - $ 2.36 B Nasdaq Global Select Market usaUSA
Annexon Annexon
ANNX
$ 3.62 4.18 % $ 561 M Nasdaq Global Select Market usaUSA
Acasti Pharma Acasti Pharma
ACST
- 4.01 % $ 150 M Nasdaq Capital Market canadaCanada
Aptose Biosciences Aptose Biosciences
APTO
- -45.71 % $ 1.2 M Nasdaq Capital Market canadaCanada
Galapagos NV Galapagos NV
GLPG
- - $ 1.83 B Nasdaq Global Select Market belgiumBelgium
Cyclacel Pharmaceuticals Cyclacel Pharmaceuticals
CYCCP
- -4.36 % $ 27 M Nasdaq Capital Market usaUSA
Idera Pharmaceuticals Idera Pharmaceuticals
IDRA
- -23.04 % $ 26.6 M Nasdaq Global Select Market usaUSA
Akero Therapeutics Akero Therapeutics
AKRO
- - $ 3.67 B Nasdaq Global Select Market,SPB usaUSA
Verona Pharma plc Verona Pharma plc
VRNA
- - $ 69.7 B Nasdaq Global Select Market britainBritain
Avenue Therapeutics Avenue Therapeutics
ATXI
- -52.27 % $ 4.45 M Nasdaq Global Select Market usaUSA
Galmed Pharmaceuticals Ltd. Galmed Pharmaceuticals Ltd.
GLMD
$ 4.63 21.05 % $ 20 M Nasdaq Capital Market israelIsrael
Achieve Life Sciences Achieve Life Sciences
ACHV
$ 6.78 0.89 % $ 296 M Nasdaq Capital Market usaUSA
Leap Therapeutics Leap Therapeutics
LPTX
- 368.57 % $ 41.9 M Nasdaq Global Market usaUSA
Atreca Atreca
BCEL
- -11.76 % $ 5.79 M Nasdaq Global Select Market usaUSA
Guardion Health Sciences Guardion Health Sciences
GHSI
- -0.31 % $ 3.64 M Nasdaq Capital Market usaUSA
Opiant Pharmaceuticals Opiant Pharmaceuticals
OPNT
- - $ 109 M Nasdaq Global Select Market usaUSA
Akouos Akouos
AKUS
- 0.23 % $ 488 M Nasdaq Global Select Market usaUSA
ImmunoGen ImmunoGen
IMGN
- - $ 7.92 B Nasdaq Global Select Market usaUSA
Vascular Biogenics Ltd. Vascular Biogenics Ltd.
VBLT
- -8.77 % $ 12.4 M Nasdaq Global Select Market israelIsrael
Bristol-Myers Squibb Company Bristol-Myers Squibb Company
BMY
$ 59.5 -3.02 % $ 121 B NYSE,SPB usaUSA
Cidara Therapeutics Cidara Therapeutics
CDTX
- - $ 1.41 B Nasdaq Global Market usaUSA
BioLineRx Ltd. BioLineRx Ltd.
BLRX
$ 1.1 -1.79 % $ 2.71 B Nasdaq Capital Market israelIsrael
Iterum Therapeutics Iterum Therapeutics
ITRM
- - $ 591 K Nasdaq Global Select Market irlandaIrlanda
Virpax Pharmaceuticals Virpax Pharmaceuticals
VRPX
- -45.12 % $ 2.85 M Nasdaq Global Select Market usaUSA
Navidea Biopharmaceuticals Navidea Biopharmaceuticals
NAVB
- -2.99 % $ 2.47 M NYSE American usaUSA
Stealth BioTherapeutics Corp Stealth BioTherapeutics Corp
MITO
- - $ 23.9 M Nasdaq Global Select Market usaUSA
OncoSec Medical Incorporated OncoSec Medical Incorporated
ONCS
- 31.87 % $ 1.61 M Nasdaq Global Select Market usaUSA
BioDelivery Sciences International BioDelivery Sciences International
BDSI
- -4.8 % $ 255 M Nasdaq Global Select Market usaUSA
Albireo Pharma Albireo Pharma
ALBO
- -0.23 % $ 916 M Nasdaq Capital Market usaUSA
bluebird bio bluebird bio
BLUE
- - $ 546 M Nasdaq Global Select Market,SPB usaUSA
Landos Biopharma Landos Biopharma
LABP
- 0.58 % $ 144 M Nasdaq Global Market usaUSA
CASI Pharmaceuticals CASI Pharmaceuticals
CASI
- - $ 35.4 M Nasdaq Capital Market usaUSA
ContraFect Corporation ContraFect Corporation
CFRX
- -5.16 % $ 5.39 M Nasdaq Capital Market usaUSA
Sigilon Therapeutics Sigilon Therapeutics
SGTX
- - $ 728 M Nasdaq Global Select Market usaUSA
NGM Biopharmaceuticals NGM Biopharmaceuticals
NGM
- - $ 127 M Nasdaq Global Select Market,SPB usaUSA
Regulus Therapeutics Regulus Therapeutics
RGLS
- - $ 155 M Nasdaq Global Select Market usaUSA
Aravive Aravive
ARAV
- -13.39 % $ 1.45 M Nasdaq Global Select Market usaUSA
Checkmate Pharmaceuticals Checkmate Pharmaceuticals
CMPI
- - $ 231 M Nasdaq Global Market usaUSA
Acer Therapeutics Acer Therapeutics
ACER
- 2.71 % $ 14 M Nasdaq Capital Market usaUSA
Axcella Health Axcella Health
AXLA
- -16.42 % $ 249 M Nasdaq Global Market usaUSA
Dynavax Technologies Corporation Dynavax Technologies Corporation
DVAX
- - $ 2.02 B Nasdaq Capital Market usaUSA
Turning Point Therapeutics Turning Point Therapeutics
TPTX
- -0.13 % $ 3.73 B Nasdaq Global Select Market,SPB usaUSA
Orgenesis Orgenesis
ORGS
- -33.86 % $ 61.2 M Nasdaq Capital Market usaUSA
TCR2 Therapeutics TCR2 Therapeutics
TCRR
- - $ 58.1 M Nasdaq Global Select Market,SPB usaUSA

References

  1. Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.